scispace - formally typeset
Search or ask a question

What does metastatic lung cancer look like on CT scan? 

Answers from top 10 papers

More filters
Papers (10)Insight
Journal ArticleDOI
W. E. Becker, Paul F. Schellhammer 
01 Oct 1986-BJUI
32 Citations
More frequent use of the abdominal CT scan in staging patients with lung cancer will render metastatic carcinoma from lung to kidney a more frequent ante mortem diagnosis.
Results suggest that lung cancers detected on CT screening are mostly curative.
Tracheal metastasis of primary non-small cell lung cancer manifested as an endotracheal nodule or eccentric wall thickening of the trachea, showing contrast enhancement with a predilection for the upper trachea on CT. During postoperative evaluation of patients with surgically resected lung cancer, the possibility of tracheal metastasis of lung cancer should be suggested when an endotracheal nodule or eccentric wall thickening is present on CT.
Lung cancer may be found by imaging tests such as chest computed tomography scan as it provides more detailed picture.
Annual spiral CT screening can detect lung cancer that is curable.
CT-guided lung biopsy is a reliable procedure that conveys a 90% sensitivity for the diagnosis of lung cancer.
CT (computed tomography) scan image is suitable for lung cancer diagnosis.
Various factors contribute to a misdiagnosis of lung cancer on chest radiographs and on CT, often very similar in nature to each other.
CT scanning has high sensitivity and specificity to detect early lung cancer.
(18)FDG PET-CT has excellent diagnostic performance for diagnosis of distant metastases in patients with lung cancer.

Related Questions

Clinical manifestations of lung cancer?4 answersClinical manifestations of lung cancer include a variety of symptoms and signs. Common symptoms reported in patients with lung cancer include chronic cough, sputum with blood, chest pain, shortness of breath, weight loss, and fatigue. Additionally, patients may present with thromboembolism (TE) and disseminated intravascular coagulation (DIC), which are more often observed in adenocarcinoma and stage IV disease. Neurological symptoms such as oculomotor nerve lesions, facial palsy, gait ataxia, and sensory neuropathy can also manifest in lung cancer patients, indicating potential central nervous system involvement. Furthermore, adverse events from lung cancer treatments, such as diarrhea, edema, nail toxicity, vomiting, stomatitis, and dry skin, can provide additional clinical clues based on the specific mechanism of action of the drugs used.
Cancer of testis with metastasis in lungs5 answersTesticular cancer can metastasize to various sites, including the lungs. Lung metastases are a common occurrence in urogenital tumors like testicular cancer, with studies highlighting the significance of pulmonary metastasectomy in improving outcomes for patients with metastatic urogenital cancers. Additionally, research has shown that testicular cancer patients with lung metastases have poorer cancer-specific survival and overall survival outcomes compared to those without lung metastases. Furthermore, cases of testicular cancer with synchronous or metachronous testicular metastasis have been reported, emphasizing the importance of thorough clinical examinations for early detection. Therefore, in cases of testicular cancer with lung metastases, a comprehensive approach involving timely diagnosis, appropriate treatment strategies, and close monitoring is crucial for optimizing patient outcomes.
What types of changes in CT DNA are indicative of lung cancer?3 answersChanges in circulating tumor DNA (ctDNA) have been identified as indicative of lung cancer. In one study, radiogenomic expression patterns combining features from CT imaging with ctDNA in serum were found to be associated with stage III lung cancer. Another study investigated perioperative dynamic changes in ctDNA and found that ctDNA concentration decreased rapidly after radical tumor resection, with the median ctDNA half-life being 35.0 minutes. Additionally, the study observed that ctDNA detection on the 3rd day after R0 resection can be used as the baseline value for postoperative lung cancer surveillance. Furthermore, the release of cell-free DNA (cfDNA) and ctDNA into the bloodstream during concurrent chemoradiation therapy (CRT) for lung cancer was observed, and specific mutations in ctDNA were found to be associated with improved survival. These findings suggest that changes in ctDNA concentration and specific mutations in ctDNA can serve as indicators of lung cancer.
Can metastatic lung cancer disappear?10 answers
Does metastasis show in blood work?8 answers
How long can you live with metastatic small cell lung cancer?9 answers